ESC Premium Access

Carvedilol vs. metoprolol tartrate on mortality in patients with heart failure with a reduced ejection fraction and atrial fibrillation or sinus rhythm: a post-hoc analysis of COMET

Congress Presentation

About the speaker

Doctor Yury Mareev

National Research Center for Therapy and Preventive Medicine, Moscow (Russian Federation)
0 follower

9 more presentations in this session

Effect of Ivabradine on Mortality in Patients with heart failure and a reduced left ventricular ejection fraction not receiving a beta-blocker: an analysis from SHIFT.

Speaker: Professor J. Cleland (Glasgow, GB)

Thumbnail

The glucagon-like peptide 1 agonist liraglutide increases heart rate in heart failure patients

Speaker: Doctor R. Tougaard (Aarhus, DK)

Thumbnail

Effect of sacubitril/valsartan on plasma biomarkers that reflect extracellular matrix regulatory mechanisms and collagen synthesis in patients with heart failure and reduced ejection fraction.

Speaker: Doctor M. Zile (Charleston, US)

Thumbnail

Long-term outcome in myocardial infarction patients with heart failure treated with aldosterone receptor antagonist in relation to ejection fraction and kidney function

Speaker: Doctor I. Lofman (Stockholm, SE)

Thumbnail

Effect of patiromer on serum K+ in hyperkalaemic patients with HF: Pooled results from the AMETHYST-DN, OPAL-HK and TOURMALINE trials

Speaker: Doctor I. Pina (Philadelphia, US)

Thumbnail

Access the full session

Can we teach heart failure drugs new tricks?

Speakers: Doctor Y. Mareev, Professor J. Cleland, Doctor R. Tougaard, Doctor M. Zile, Doctor I. Lofman...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

Related content

ESC Premium Access

cardAIc-cluster: Redefining beta-blocker response in heart failure

30 August 2021

ESC Premium Access

Are the results of the RATE-AF trial reproducible in daily practice? Clinical outcomes with digoxin vs beta-blocker for heart rate control in permanent atrial fibrillation

30 August 2021

Open Access

First-line cryoablation for Atrial Fibrillation: Turning evidence into practice.

27 August 2021

ESC 365 is supported by

logo Novo Nordisk